The Discovery of Selumetinib
Add to My Pictures
|Title:||The Discovery of Selumetinib|
More than 30 years of NCI-led and NCI-supported research culminated in clinical trials of selumetinib for kids with neurofibromatosis type 1 (NF1) and associated tumors called plexiform neurofibromas (PNs). With Food and Drug Administration (FDA) approval, selumetinib is now the first effective treatment for kids with PNs that can't be removed by surgery.
See also www.cancer.gov/research/progress/discovery/selumetinib-plexiform-neurofibromas.
Cancer Types -- Childhood / Pediatric Cancers
Infographics -- National Cancer Institute
|Type:||Color, Illustration (JPEG format)|
|Source:||National Cancer Institute (NCI)|
|Date Created:||April 17, 2020|
|Date Added:||April 20, 2020|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|